Literature DB >> 2504517

Human immunodeficiency virus (HIV) infection in haemophiliacs: long-term prognostic significance of the HIV serologic pattern.

K Raska1, H C Kim, K Raska1, E Martin, J Raskova, P Saidi.   

Abstract

To identify markers of prognostic value in the course of HIV disease, immunologic parameters and profiles of HIV antibodies and antigen were studied in 60 haemophiliacs. The 43 HIV-seropositive subjects were followed prospectively over a 4 year period with a retrospective analysis as well of their frozen plasma for HIV markers. This group had a significant decrease in number of helper/inducer T lymphocytes as compared with 17 HIV seronegative subjects. The degree of changes correlated with the stage of disease, with the most severe depletion of CD4 cells in those who developed AIDS. Counts of B cells and platelets were also lower in HIV-infected haemophiliacs. Ten out of 12 AIDS patients had undetectable antibodies to HIV p24 antigen; low levels of p24 antibody were also seen in six out of 15 subjects with lymphadenopathy (CDC stage III), but in only two out of 16 asymptomatic subjects (CDC stage II). Sustained HIV p24 antigenaemia (greater than 30 pg/ml) was seen in 10 AIDS patients, in five subjects with lymphadenopathy and in two asymptomatic haemophiliacs. Initial HIV serologic profiles, obtained when all patients were asymptomatic, were highly predictive for progression of the HIV infection: the initial pattern of low anti-p24 antibody and positive p24 antigenaemia conferred the worst prognosis, with all patients in this group developing ARC or AIDS within 36 months, whereas an initial high level of anti-p24 without p24 antigenaemia was associated with relatively the best prognosis. Of such subjects, 58% have remained clinically asymptomatic after 48 months of the study (P less than 0.00001). The serologic profile of HIV antibody pattern and HIV antigen in haemophilic patients thus already provides important prognostic information at an early stage of HIV infection.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2504517      PMCID: PMC1541939     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  15 in total

1.  Persistent HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDS.

Authors:  J M Lange; D A Paul; H G Huisman; F de Wolf; H van den Berg; R A Coutinho; S A Danner; J van der Noordaa; J Goudsmit
Journal:  Br Med J (Clin Res Ed)       Date:  1986-12-06

2.  Suppressor cells in end-stage renal disease. Functional assays and monoclonal antibody analysis.

Authors:  J Raskova; I Ghobrial; S M Shea; R P Eisinger; K Raska
Journal:  Am J Med       Date:  1984-05       Impact factor: 4.965

3.  Development and early natural history of HTLV-III antibodies in persons with hemophilia.

Authors:  M E Eyster; J J Goedert; M G Sarngadharan; S H Weiss; R C Gallo; W A Blattner
Journal:  JAMA       Date:  1985-04-19       Impact factor: 56.272

4.  Natural history of acquired immunodeficiency syndrome in hemophilic patients.

Authors:  H C Kim; K Nahum; K Raska; D J Gocke; M Kosmin; G I Karp; P Saidi
Journal:  Am J Hematol       Date:  1987-02       Impact factor: 10.047

5.  Predisposition for cholera of individuals with O blood group. Possible evolutionary significance.

Authors:  R I Glass; J Holmgren; C E Haley; M R Khan; A M Svennerholm; B J Stoll; K M Belayet Hossain; R E Black; M Yunus; D Barua
Journal:  Am J Epidemiol       Date:  1985-06       Impact factor: 4.897

6.  Effect of danazol on clotting factor levels, bleeding incidence, factor infusion requirements, and immune parameters in hemophilia.

Authors:  P Saidi; B Z Lega; H C Kim; K Raska
Journal:  Blood       Date:  1986-09       Impact factor: 22.113

7.  Flow cytometric analysis of lymphocyte phenotypes in AIDS using monoclonal antibodies and simultaneous dual immunofluorescence.

Authors:  D P Stites; C H Casavant; T M McHugh; A R Moss; S L Beal; J L Ziegler; A M Saunders; N L Warner
Journal:  Clin Immunol Immunopathol       Date:  1986-02

8.  Prognostic importance of antibodies to human immunodeficiency virus by recombinant immunoassay and Western blot techniques in HIV antibody-positive hemophiliacs.

Authors:  M V Ragni; T A O'Brien; D Reed; J A Spero; J H Lewis
Journal:  AIDS Res Hum Retroviruses       Date:  1988-06       Impact factor: 2.205

9.  Natural history of human immunodeficiency virus infections in hemophiliacs: effects of T-cell subsets, platelet counts, and age.

Authors:  M E Eyster; M H Gail; J O Ballard; H Al-Mondhiry; J J Goedert
Journal:  Ann Intern Med       Date:  1987-07       Impact factor: 25.391

10.  Expansion of a minor subpopulation of peripheral blood lymphocytes (T8+/Leu 7+) in patients with haemophilia.

Authors:  H W Ziegler-Heitbrock; W Schramm; D Stachel; H Rumpold; D Kraft; D Wernicke; K von der Helm; J Eberle; F Deinhardt; E P Rieber
Journal:  Clin Exp Immunol       Date:  1985-09       Impact factor: 4.330

View more
  2 in total

1.  Phenotypical and functional evaluation of CD8+/S6F1+ T lymphocytes in haemophiliac individuals with HIV-1 infection.

Authors:  F Cavallin; A Traldi; R Zambello
Journal:  Clin Exp Immunol       Date:  1993-07       Impact factor: 4.330

2.  Biomarkers predicting progression of human immunodeficiency virus-related disease.

Authors:  Amar Kanekar
Journal:  J Clin Med Res       Date:  2010-03-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.